Announcements Trials
Browse Landscape

Phase

Phase NA 16Phase 2 15Phase 3 13Phase 1/2 4Phase 1 4Phase EARLY_PHASE1 3Phase 4 3Phase 2/3 1

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 2Breast Cancer Female 1

Interventions

Magnetic Resonance Spectroscopy 23Metformin 14pembrolizumab 12Radiotherapy 12Biopsy 11Nivolumab 9Fluorouracil 9Cyclophosphamide 9Temozolomide 7Radiation 7Bevacizumab 7gallium 68 PSMA-11 6Sirolimus 6Rituximab 6Letrozole 6Etoposide 6Cisplatin 6Aspirin 6olaparib 5Surveys and Questionnaires 5Radiosurgery 5Oxaliplatin 5Irinotecan 5Indocyanine Green 5Granulocyte Colony-Stimulating Factor 5Fluorodeoxyglucose F18 5Dexamethasone 5aldesleukin 4Surgical Procedures, Operative 4Proflavine 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Completed × Vitamin D × Clear all
NCT03629717 2024-10-16

RANKL Inhibition and Breast Tissue Biomarkers

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
10 enrolled
Breast

Breast Neoplasms

NCT05331807 2024-05-08

Omega-3 and Vitamin D Supplementation in Breast Cancer Women

Universiti Sains Malaysia

Phase EARLY_PHASE1 Completed
88 enrolled
Breast

Breast Cancer Female

NCT00263185 2014-09-22

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

Washington University School of Medicine

Phase EARLY_PHASE1 Completed
63 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡